🔴 BreakingDrug approvalRSSYesterday
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
The FDA has approved a new medicine called Hepcludex to treat chronic hepatitis delta virus (HDV) infection. HDV is a serious liver virus that only affects people who already have hepatitis B. This is the first FDA-approved treatment specifically for HDV, and it can be used in adults whose livers are not yet severely scarred or who have some scarring but stable liver function.
WHY IT MATTERSFor the first time, adults with chronic HDV infection now have an FDA-approved treatment option, ending decades without any approved therapy for this serious liver disease.